Mechanisms of action and potential uses of hyaluronan in dogs with osteoarthritis

Journal of the American Veterinary Medical Association

Volumn 221, Issue 7, 2002, Pages 944-950

  Kuroki, Keiichi ^a   Cook, James L ^a   Kreeger, John M ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID;

DOG; DRUG MECHANISM; HOMEOSTASIS; HUMAN; NONHUMAN; OSTEOARTHRITIS; PATHOPHYSIOLOGY; REVIEW; TREATMENT OUTCOME;

CANIS FAMILIARIS;

EID: 0036786255     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2002.221.944     Document Type: Review

References (93)

1. Johnston SA. Osteoarthritis. Joint anatomy, physiology, and pathobiology. Vet Clin North Am Small Anim Pract 1997;27:699-723.
2. Butler J, Rydell NW, Balazs EA. Hyaluronic acid in synovial fluid. VI. Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of arthritis in track horses. Acta Vet Scand 1970;11:139-155.
3. Auer JA, Fackelman GE, Gingerich DA, et al. Effect of hyaluronic acid in naturally occurring and experimentally induced osteoarthritis. Am J Vet Res 1980;41:568-574.
4. Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol 1998;25:2203-2212.
5. Wobig M, Dickhut A, Maier R, et al. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 1998;20:410-423.
6. Brandt KD, Block JA, Michalski JP, et al. Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. ORTHOVISC Study Group. Clin Orthop 2001;385:130-143.
7. Listrat V, Ayral X, Patarnello F, et al. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartilage 1997;5:153-160.
8. Frizziero L, Govoni E, Bacchini P. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clin Exp Rheumatol 1998;16:441-449.
9. Guidolin DD, Ronchetti IP, Lini E, et al. Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500-730 kDa sodium hyaluronate (Hyalgan) and methylprednisolone acetate on primary osteoarthritis of the knee. Osteoarthritis Cartilage 2001;9:371-381.
10. Pasquali Ronchetti I, Guerra D, Taparelli F, et al. Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate (Hyalgan) and methylprednisolone acetate (Depomedrol) in osteoarthritis. Rheumatology 2001;40:158-169.
11. Kobayashi K, Amiel M, Harwood FL, et al. The long-term effects of hyaluronan during development of osteoarthritis following partial meniscectomy in a rabbit model. Osteoarthritis Cartilage 2000;8:359-365.
12. Abatangelo G, Botti P, Del Bue M, et al. Intraarticular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. I. Biochemical results. Clin Orthop 1989;241:278-285.
13. Schiavinato A, Lini E, Guidolin D, et al. Intraarticular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. II. Morphological findings. Clin Orthop 1989;241:286-299.
14. Wenz W, Breusch SJ, Graf J, et al. Ultrastructural findings after intraarticular application of hyaluronan in a canine model of arthropathy. J Orthop Res 2000;18:604-612.
15. Neame PJ. Extracellular matrix of cartilage: proteoglycan. In: Woessner FJ Jr, Howell DS. Joint cartilage degradation. New York: Marcel Dekker Inc, 1993;109-138.
16. Mankin HJ, Mow VC, Buckwalter JA, et al. Articular cartilage structure, composition, and function. In: Buckwalter JA, Einhorn TA, Simon SR, eds. Orthopaedic basic science. Rosemont, Ill: American Academy of Orthopaedic Surgeons, 2000;443-470.
17. Ishida O, Tanaka Y, Morimoto I, et al. Chondrocytes are regulated by cellular adhesion through CD44 and hyaluronic acid pathway. J Bone Miner Res 1997;12:1657-1663.
18. Lisignoli G, Grassi F, Zini N, et al. Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan: evidence for CD44 and CD54 (intercellular adhesion molecule 1) involvement. Arthritis Rheum 2001;44:1800-1807.
19. Uebelhart D, Williams JM. Effects of hyaluronic acid on cartilage degradation. Curr Opin Rheumatol 1999;11:427-435.
20. Mow VC, Flatow EL, Ateshian GA. Biomechanics. In: Buchwalter JA, Einhorn TA, Simon SR, eds. Orthopaedic basic science. Rosemont, Ill: American Academy of Orthopaedic Surgeons, 2000;133-180.
21. Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol 1993;20(suppl 39):3-9.
22. Dahl LB, Dahl IM, Engstrom-Laurent A, et al. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 1985;44:817-822.
23. Tulamo RM, Heiskanen T, Salonen M. Concentration and molecular weight distribution of hyaluronate in synovial fluid from clinically normal horses and horses with diseased joints. Am J Vet Res 1994;55:710-715.
24. Smith GN Jr, Mickler EA, Myers SL, et al. Effect of intraarticular hyaluronan injection on synovial fluid hyaluronan in the early stage of canine post-traumatic osteoarthritis. J Rheumatol 2001;28:1341-1346.
25. Arican M, Carter SD, May C, et al. Hyaluronan in canine arthropathies. J Comp Pathol 1994;111:185-195.
26. Marshall WK. Intra-articular hyaluronan therapy. Curr Opin Rheumatol 2000;12:468-474.
27. Peyron JG. Intraarticular hyaluronan injections in the treatment of osteoarthritis: state-of-the-art review. J Rheumatol 1993;20(suppl 39):10-15.
28. Brown TJ, Laurent UB, Fraser JR. Turnover of hyaluronan in synovial joints: elimination of labelled hyaluronan from the knee joint of the rabbit. Exp Physiol 1991;76:125-134.
29. Laurent UB, Fraser JR, Engstrom-Laurent A, et al. Catabolism of hyaluronan in the knee joint of the rabbit. Matrix 1992;12:130-136.
30. Berkowitz D. Proceedings of the United States Food and Drug Administration Advisory Panel on Orthopaedic and Rehabilitation Devices Panel, 11/21/96. Fairfax, Va: CASET Associates Ltd, 1996;87.
31. Vuorio E, Einola S, Hakkarainen S, et al. Synthesis of underpolymerized hyaluronic acid by fibroblasts cultured from rheumatoid and non-rheumatoid synovitis. Rheumatol Int 1982;2:97-102.
32. Smith MM, Ghosh P. The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment. Rheumatol Int 1987;7:113-122.
33. Balaza EA, Denlinger JL. Sodium hyaluronate acid and joint function. J Equine Vet Sci 1985;5:217-228.
34. Peyron JG, Balazs EA. Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints. Pathol Biol 1974;22:731-736.
35. Brandt KD, Smith GN Jr, Simon LS. Intraarticular injection of hyaluronan as treatment for knee osteoarthritis: what is the evidence? Arthritis Rheum 2000;43:1192-1203.
36. Pozo MA, Balazs EA, Belmonte C. Reduction of sensory responses to passive movements of inflamed knee joints by hylan, a hyaluronan derivative. Exp Brain Res 1997;116:3-9.
37. Gotoh S, Onaya J, Abe M, et al. Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. Ann Rheum Dis 1993;52:817-822.
38. Forrester JV, Balazs EA. Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology 1980;40:435-446.
39. Forrester JV, Wilkinson PC. Inhibition of leukocyte locomotion by hyaluronic acid. J Cell Sci 1981;48:315-331.
40. Yasui T, Akatsuka M, Tobetto K, et al. The effect of hyaluronan on interleukin-1 alpha-induced prostaglandin E2 production in human osteoarthritic synovial cells. Agents Actions 1992;37:155-156.
41. Akatsuka M, Yamamoto Y, Tobetto K, et al. In vitro effects of hyaluronan on prostaglandin E2 induction by interleukin-1 in rabbit articular chondrocytes. Agents Actions 1993;38:122-125.
42. Punzi L, Schiavon F, Cavasin F, et al. The influence of intraarticular hyaluronic acid on PGE2 and cAMP of synovial fluid. Clin Exp Rheumatol 1989;7:247-250.
43. Homandberg GA, Hui F, Wen C, et al. Hyaluronic acid suppresses fibronectin fragment mediated cartilage chondrolysis: I. In vitro. Osteoarthritis Cartilage 1997;5:309-319.
44. Williams JM, Plaza V, Hui F, et al. Hyaluronic acid suppresses fibronectin fragment mediated cartilage chondrolysis: II. In vivo. Osteoarthritis Cartilage 1997;5:235-240.
45. Kang Y, Eger W, Koepp H, et al. Hyaluronan suppresses fibronectin fragment-mediated damage to human cartilage explant cultures by enhancing proteoglycan synthesis. J Orthop Res 1999;17:858-869.
46. Shimazu A, Jikko A, Iwamoto M, et al. Effects of hyaluronic acid on the release of proteoglycan from the cell matrix in rabbit chondrocyte cultures in the presence and absence of cytokines. Arthritis Rheum 1993;36:247-253.
47. Morris EA, Wilcon S, Treadwell BV Inhibition of interleukin 1-mediated proteoglycan degradation in bovine articular cartilage explants by addition of sodium hyaluronate. Am J Vet Res 1992;53:1977-1982.
48. Larsen NE, Lombard KM, Parent EG, et al. Effect of hylan on cartilage and chondrocyte cultures. J Orthop Res 1992;10:23-32.
49. Frean SP, Abraham LA, Lees P In vitro stimulation of equine articular cartilage proteoglycan synthesis by hyaluronan and carprofen. Res Vet Sci 1999;67:183-190.
50. Kawasaki K, Ochi M, Uchio Y, et al. Hyaluronic acid enhances proliferation and chondroitin sulfate synthesis in cultured chondrocytes embedded in collagen gels. J Cell Physiol 1999;179:142-148.
51. Sonoda M, Harwood FL, Wada Y, et al. The effects of hyaluronan on the meniscus and on the articular cartilage after partial meniscectomy. Am J Sports Med 1997;25:755-762.
52. Henrotin Y, Reginster JY. Anabolic events in osteoarthritis. Osteoarthritis Cartilage 1999;7:310-312.
53. Noble PW, Lake FR, Henson PM, et al. Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages. J Clin Invest 1993;91:2368-2377.
54. Comer JS, Kincaid SA, Baird AN, et al. Immunolocalization of stromelysin, tumor necrosis factor (TNF) alpha, and TNF receptors in atrophied canine articular cartilage treated with hyaluronic acid and transforming growth factor beta. Am J Vet Res 1996;57:1488-1496.
55. Takahashi K, Goomer RS, Harwood F, et al. The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1beta(IL-1beta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritis. Osteoarthritis Cartilage 1999;7:182-190.
56. Nonaka T, Kikuchi H, Ikeda T, et al. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis. J Rheumatol 2000;27:997-1004.
57. Yasui T, Akatsuka M, Tobetto K, et al. Effects of hyaluronan on the production of stromelysin and tissue inhibitor of metalloproteinase-1 (TIMP-1) in bovine articular chondrocytes. Biomed Res 1992;13:343-348.
58. Cawston TE. Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacol Ther 1996;70:163-182.
59. Dean DD, Martel-Pelletier J, Pelletier JP, et al. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 1989;84:678-685.
60. Pelletier JP, Mineau F, Faure MP, et al. Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis. Arthritis Rheum 1990;33:1466-1476.
61. Yuan GH, Masuko-Hongo K, Sakata M, et al. The role of C-C chemokines and their receptors in osteoarthritis. Arthritis Rheum 2001;44:1056-1070.
62. Alaaeddine N, Olee T, Hashimoto S, et al. Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation. Arthritis Rheum 2001;44:1633-1643.
63. Fukuda K, Oh M, Asada S, et al. Sodium hyaluronate inhibits interleukin-1-evoked reactive oxygen species of bovine articular chondrocytes. Osteoarthritis Cartilage 2001;9:390-392.
64. Takahashi K, Hashimoto S, Kubo T, et al. Hyaluronan suppressed nitric oxide production in the meniscus and synovium of rabbit osteoarthritis model. J Orthop Res 2001;19:500-503.
65. Stadler J, Stefanovic-Racic M, Billiar TR, et al. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol 1991;147:3915-3920.
66. Cao M, Westerhausen-Larson A, Niyibizi C, et al. Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target. Biochem J 1997;324:305-310.
67. Taskiran D, Stefanovic-Racic M, Georgescu H, et al. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biochem Biophys Res Commun 1994;200:142-148.
68. Saari H, Sorsa T, Konttinen YT. Reactive oxygen species and hyaluronate in serum and synovial fluid in arthritis. Int J Tissue React 1990;12:81-89.
69. Blanco FJ, Ochs RL, Schwarz H, et al. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 1995;146:75-85.
70. Hashimoto S, Takahashi K, Amiel D, et al. Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arthritis Rheum 1998;41:1266-1274.
71. Takahashi K, Hashimoto S, Kubo T, et al. Effect of hyaluronan on chondrocyte apoptosis and nitric oxide production in experimentally induced osteoarthritis. J Rheumatol 2000;27:1713-1720.
72. Hashimoto S, Ochs RL, Rosen F, et al. Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc Natl Acad Sci U S A 1998;95:3094-3099.
73. Stadler J, Stefanovic-Racic M, Billiar TR, et al. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol 1991;147:3915-3920.
74. Murrell GA, Jang D, Williams RJ. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 1995;206:15-21.
75. Pelletier JP, Jovanovic D, Fernandes JC, et al. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum 1998;41: 1275-1286.
76. Abramson SB. The role of COX-2 produced by cartilage in arthritis. Osteoarthritis Cartilage 1999;7:380-381
77. Di Battista JA, Dore S, Morin N, et al. Prostaglandin E2 stimulates insulin-like growth factor binding protein-4 expression and synthesis in cultured human articular chondrocytes: possible mediation by Ca(++)-calmodulin regulated processes. J Cell Biochem 1997;65:408-419.
78. Blanco Garcia FJ. Catabolic events in osteoarthritic cartilage. Osteoarthritis Cartilage 1999;7:308-309.
79. van de Loo FA, Joosten LA, van Lent PL, et al. Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen-and zymosan-induced arthritis. Arthritis Rheum 1995;38:164-172.
80. Joosten LA, Helsen MM, Saxne T, et al. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. J Immunol 1999;163:5049-5055.
81. Evanich DJ, Evanich CJ, Wright MB, et al. Efficacy of intraarticular hyaluronic acid injections in knee osteoarthritis. Clin Orthop 2001;390:173-181.
82. Henderson EB, Smith EC, Pegley E, et al. Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. Ann Rheum Dis 1994;53:529-534.
83. Bernardeau C, Bucki B, Liote E Acute arthritis after intraarticular hyaluronate injection: onset of effusions without crystal. Ann Rheum Dis 2001;60:518-520.
84. Martens PB. Bilateral symmetric inflammatory reaction to hylan G-F 20 injection. Arthritis Rheum 2001;44:978-979.
85. Marshall KW, Manolopoulos V, Mancer K, et al. Amelioration of disease severity by intraarticular hylan therapy in bilateral canine osteoarthritis. J Orthop Res 2000;18:416-425.
86. Smith GN Jr, Myers SL, Brandt KD, et al. Diacerhein treatment reduces the severity of osteoarthritis in the canine cruciate-deficiency model of osteoarthritis. Arthritis Rheum 1998;42:545-554.
87. Keller WG, Aron DN, Rowland GN, et al. The effect of trans-stifle external skeletal fixation and hyaluronic acid therapy on articular cartilage in the dog. Vet Surg 1994;23:119-128.
88. Philips MW. Clinical trial comparison of intra-articular sodium hyaluronan products in horses. J Equine Vet Sci 1989;9:39-40.
89. Wobig M, Bach G, Beks P, et al. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. Clin Ther 1999;21:1549-1562.
90. Gingerich DA, Auer JA, Fackelman GE. Effect of exogenous hyaluronic acid on joint function in experimentally induced equine osteoarthritis: dosage litration studies. Res Vet Sci 1981;30:192-197.
91. Ghosh P, Read R. Armstrong S, et al. The effects of intraarticular administration of hyaluronan in a model of early osteoarthritis in sheep. 1. Gait analysis and radiological and morphological studies. Semin Arthritis Rheum 1993;22(suppl 1):18-30.
92. Ghosh P, Read R, Numata Y, et al. The effects of intraarticular administration of hyaluronan in a model of early osteoarthritis in sheep. II. Cartilage composition and proteoglycan metabolism. Semin Arthritis Rheum 1993;22(suppl 1):31-42.
93. Pond MJ, Nuki G. Experimentally induced osteoarthritis in the dog. Ann Rheum Dis 1973;32:387-388.